| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1819 | 2020 |
| Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort … JL McQuade, CR Daniel, KR Hess, C Mak, DY Wang, RR Rai, JJ Park, ... The Lancet Oncology 19 (3), 310-322, 2018 | 529 | 2018 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 281 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Impact of age on outcomes with immunotherapy for patients with melanoma AS Betof, RD Nipp, A Giobbie‐Hurder, RAN Johnpulle, K Rubin, ... The oncologist 22 (8), 963-971, 2017 | 165 | 2017 |
| The evolving use of electronic health records (EHR) for research E Kim, SM Rubinstein, KT Nead, AP Wojcieszynski, PE Gabriel, ... Seminars in radiation oncology 29 (4), 354-361, 2019 | 159 | 2019 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 141 | 2020 |
| Immune-mediated complications after hematopoietic stem cell transplantation Z Li, SM Rubinstein, R Thota, M Savani, E Brissot, BE Shaw, NS Majhail, ... Biology of Blood and Marrow Transplantation 22 (8), 1368-1375, 2016 | 61 | 2016 |
| EPR oxygen images predict tumor control by a 50% tumor control radiation dose M Elas, JM Magwood, B Butler, C Li, R Wardak, R DeVries, ED Barth, ... Cancer research 73 (17), 5328-5335, 2013 | 60 | 2013 |
| The COVID-19 and cancer consortium: a collaborative effort to understand the effects of COVID-19 on patients with cancer SM Rubinstein, JA Steinharter, J Warner, BI Rini, S Peters, TK Choueiri Cancer cell 37 (6), 738-741, 2020 | 58 | 2020 |
| COVID-19 and Cancer Consortium NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study …, 2020 | 55 | 2020 |
| Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents RF Cornell, SZ Goldhaber, BG Engelhardt, J Moslehi, M Jagasia, ... British journal of haematology 190 (4), 555-561, 2020 | 48 | 2020 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| The impact of nonsteroidal anti‐inflammatory drugs, beta blockers, and metformin on the efficacy of anti‐PD‐1 therapy in advanced melanoma DY Wang, JL McQuade, RR Rai, JJ Park, S Zhao, F Ye, KE Beckermann, ... The oncologist 25 (3), e602-e605, 2020 | 44 | 2020 |
| CancerLinQ: origins, implementation, and future directions SM Rubinstein, JL Warner JCO clinical cancer informatics 2, 1-7, 2018 | 43 | 2018 |
| BRAF internal deletions and resistance to BRAF/MEK inhibitor therapy DB Johnson, MA Childress, ZR Chalmers, GM Frampton, SM Ali, ... Pigment cell & melanoma research 31 (3), 432-436, 2018 | 34 | 2018 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 29 | 2023 |
| Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and … TK Choueiri, C Labaki, Z Bakouny, CY Hsu, AL Schmidt, G de Lima Lopes, ... The Lancet Regional Health–Americas 19, 2023 | 26 | 2023 |
| Hyperviscosity syndrome in paraprotein secreting conditions including Waldenstrom macroglobulinemia A Weaver, S Rubinstein, RF Cornell Frontiers in Oncology 10, 815, 2020 | 25 | 2020 |
| Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium A Elkrief, C Hennessy, NM Kuderer, SM Rubinstein, E Wulff-Burchfield, ... The Lancet Healthy Longevity 3 (3), e143-e152, 2022 | 19 | 2022 |
